Nolla Health Pilots First US AI Prescriptions for 8 Acne Drugs

Clinician oversight for the pilot will be phased in, beginning with manual approval for the first 100 patients and moving to weekly reviews for the next 400. In the final phase, physicians will monitor at least 10% of prescriptions each month. This automation reduces patient costs to approximately $50 a month for compounded medications, down from the $150 to $300 typically spent on dermatology visits. State regulators granted the company a narrow exemption from laws requiring a licensed human prescriber.